Natera Inc
(FRA:45E)
€
275.8
+9.6 (+3.61%)
Market Cap: 40.11 Bil
Enterprise Value: 39.74 Bil
PE Ratio: 0
PB Ratio: 26.55
GF Score: 77/100 Natera Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 18, 2020 / 07:50PM GMT
Release Date Price:
€41.6
(+0.97%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Great. Welcome. This is Dan Brennan. I cover tools, diagnostics, pharma services here at UBS. Day 1 of our virtual conference. So thanks for anyone on the phone or on the webcast participating. Really pleased to be joined with me -- on the phone with the Chief Financial Officer of Natera, Mike Brophy. Mike and I actually go way back, having overlapped at a predecessor broker firm before Mike went on to greener pastures at Natera.
So Mike, welcome, and thanks for being with us.
Michael Brophy
Natera, Inc. - CFO
Thanks, Dan. It's good to be with you.
Questions & Answers
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Awesome. Well, feel free, anyone on the phone, to punch in some questions into the webcast. I will do my best. And we've gotten 1 or 2 each presentation, certainly, will do my best to
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot